Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isao Taguchi

Showing results (151-160 of 159) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 159 results.
Cardiovascular Diabetology|April 14, 2017
Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trialAtsushi Tanaka, Michio Shimabukuro, Yosuke Okada, et al.
Cardiovascular Diabetology|September 14, 2016
Rationale and design of a multicenter randomized controlled study to evaluate the preventive effect of ipragliflozin on carotid atherosclerosis: the PROTECT studyAtsushi Tanaka, Toyoaki Murohara, Isao Taguchi, et al.
Cardiovascular Diabetology|December 5, 2025
Effects of finerenone on arterial stiffness and cardiorenal biomarkers in patients with type 2 diabetes and chronic kidney disease: a randomised placebo-controlled mechanistic trial (FIVE-STAR)Atsushi Tanaka, Muthiah Vaduganathan, Takumi Imai, et al.
European Heart Journal|August 31, 2024
In-hospital initiation of angiotensin receptor-neprilysin inhibition in acute heart failure: the PREMIER trialAtsushi Tanaka, Keisuke Kida, Yuya Matsue, et al.
Kidney International Reports|May 25, 2026
Randomized Trial of Finerenone on Urinary Albumin-to-Creatinine Ratio in Type 2 Diabetes Mellitus and CKDAtsushi Tanaka, Takumi Imai, Muthiah Vaduganathan, et al.
British Journal of Pharmacology|May 21, 2024
A novel ryanodine receptor 2 inhibitor, M201-A, enhances natriuresis, renal function and lusi-inotropic actions: Preclinical and phase I studyNoboru Kaneko, Christopher M Loughrey, Godfrey Smith, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 6, 2025
Pharmacological study of the safety, efficacy, and potential of M201-A on paroxysmal and persistent atrial fibrillationNoboru Kaneko, Godfrey L Smith, Christopher M Loughrey, et al.
Circulation|May 9, 2018
High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): A Randomized Superiority TrialIsao Taguchi, Satoshi Iimuro, Hiroshi Iwata, et al.
European Heart Journal. Cardiovascular Imaging|June 12, 2019
Anomalous origin of the coronary artery coursing between the great vessels presenting with a cardiovascular event (J-CONOMALY Registry)Koichi Nagashima, Takafumi Hiro, Daisuke Fukamachi, et al.
Pageof 16

Showing results (151-160 of 159) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 159 results.
Cardiovascular Diabetology|April 14, 2017
Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trialAtsushi Tanaka, Michio Shimabukuro, Yosuke Okada, et al.
Cardiovascular Diabetology|September 14, 2016
Rationale and design of a multicenter randomized controlled study to evaluate the preventive effect of ipragliflozin on carotid atherosclerosis: the PROTECT studyAtsushi Tanaka, Toyoaki Murohara, Isao Taguchi, et al.
Cardiovascular Diabetology|December 5, 2025
Effects of finerenone on arterial stiffness and cardiorenal biomarkers in patients with type 2 diabetes and chronic kidney disease: a randomised placebo-controlled mechanistic trial (FIVE-STAR)Atsushi Tanaka, Muthiah Vaduganathan, Takumi Imai, et al.
European Heart Journal|August 31, 2024
In-hospital initiation of angiotensin receptor-neprilysin inhibition in acute heart failure: the PREMIER trialAtsushi Tanaka, Keisuke Kida, Yuya Matsue, et al.
Kidney International Reports|May 25, 2026
Randomized Trial of Finerenone on Urinary Albumin-to-Creatinine Ratio in Type 2 Diabetes Mellitus and CKDAtsushi Tanaka, Takumi Imai, Muthiah Vaduganathan, et al.
British Journal of Pharmacology|May 21, 2024
A novel ryanodine receptor 2 inhibitor, M201-A, enhances natriuresis, renal function and lusi-inotropic actions: Preclinical and phase I studyNoboru Kaneko, Christopher M Loughrey, Godfrey Smith, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 6, 2025
Pharmacological study of the safety, efficacy, and potential of M201-A on paroxysmal and persistent atrial fibrillationNoboru Kaneko, Godfrey L Smith, Christopher M Loughrey, et al.
Circulation|May 9, 2018
High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): A Randomized Superiority TrialIsao Taguchi, Satoshi Iimuro, Hiroshi Iwata, et al.
European Heart Journal. Cardiovascular Imaging|June 12, 2019
Anomalous origin of the coronary artery coursing between the great vessels presenting with a cardiovascular event (J-CONOMALY Registry)Koichi Nagashima, Takafumi Hiro, Daisuke Fukamachi, et al.
Pageof 16